CBF Cobra Bio-Man.

 

TIDMCBF 
 
RNS Number : 7965X 
Cobra Bio-Manufacturing PLC 
21 August 2009 
 

 
 
+---------------------------------------+---------------------------------------+ 
| For Immediate Release                 |                        21 August 2009 | 
+---------------------------------------+---------------------------------------+ 
 
 
Cobra Biomanufacturing Plc ("Cobra") 
 
 
Directorate Change 
 
 
Cobra Biomanufacturing Plc (AIM: CBF) the international provider of 
biopharmaceutical manufacturing services, today announces with immediate effect 
the appointment of Daniel Robert Chapchal as Non Executive Chairman, following 
an offer by Peter Fothergill to step down as Non Executive Chairman. This was 
duly accepted by the Board of Directors. 
 
 
Danny Chapchal, aged 64 has a reputation for managing turnarounds and helping 
early stage companies bring new technology to market. His primary role at Cobra 
will be to develop strategic partnerships and explore financing arrangements for 
the business. 
 
 
"Cobra is an organisation with an excellent reputation in the biopharmaceutical 
market that has experienced difficulties as a result of the global economic 
downturn. It has a strong customer base and has developed market leading 
intellectual property for the oral delivery of vaccines. My objective is to 
maximise shareholder value," said Danny Chapchal. 
 
 
"The Cobra Board would like to thank Peter for his contribution to Cobra over 
many years, particularly as Chairman since Cobra's AIM listing in 2002. We also 
welcome Danny, who has the full support of our major shareholder to the Board as 
our new Non Executive Chairman. We look forward to working with Danny whose 
reputation, connections and belief in Cobra will be invaluable in helping to 
move the business forward through this crucial stage of our development." said 
Simon Saxby, Chief Executive. 
 
 
Danny Chapchal is an investor alongside Lord Young of Graffham in digital valve 
developer Camcon Limited and security speciality TSSI Systems Limited. He is a 
Chief Executive and Deputy Chairman of Camcon and Executive Chairman of TSSI. He 
has also previously served as a Non Executive Director of Trace Plc. 
 
 
Daniel Robert Chapchal's current directorships are as follows: 
 
 
Turnmell Limited: Chairman & Chief Executive 
TSSI Systems Limited: Executive Chairman 
Camcon Limited: Chief Executive and Deputy Chairman 
Camcon Oil & Gas Limited (Dormant): Director 
Camcon Medical Limited (Dormant): Director 
Camcon Automotive Limited (Dormant): Director 
Chesters Developments Limited: Director 
 
 
Daniel Robert Chapchal's directorships over the previous 5 years are as follows: 
 
 
Acus Management Partnership Limited 
Acus (Channel Island) Limited 
Flying Null Limited 
Hazard Chase Limited 
Hazard Chase Holding Limited 
Ozone Industrial Limited 
Scipher Plc (in administration)* 
Trace Group Plc 
 
 
 
*Daniel Robert Chapchal was a director of Schipher Plc which was placed into 
administrative receivership on 28 September 2004. 
 
 
There are no further matters which are required to be announced with regard to 
this appointment under paragraph (g) of Schedule 2 of the AIM Rules for 
Companies. 
 
 
For further information, please contact: 
 
 
+--------------------------------------------------+---------------------------+ 
| Cobra Biomanufacturing Plc                       | Tel: +44 (0) 1782 714 181 | 
+--------------------------------------------------+---------------------------+ 
| Danny Chapchal, Non Executive Chairman           |                           | 
+--------------------------------------------------+---------------------------+ 
| Simon Saxby, Chief Executive                     |                           | 
+--------------------------------------------------+---------------------------+ 
| Peter Coleman, Finance Director                  |                           | 
+--------------------------------------------------+---------------------------+ 
|                                                  |                           | 
+--------------------------------------------------+---------------------------+ 
| Buchanan Communications                          | Tel: +44 (0) 207 466 5000 | 
+--------------------------------------------------+---------------------------+ 
| Tim Anderson/Rebecca Skye Dietrich               |                           | 
+--------------------------------------------------+---------------------------+ 
|                                                  |                           | 
+--------------------------------------------------+---------------------------+ 
| Seymour Pierce (NOMAD & Broker)                  | Tel: +44 (0) 20 107 8000  | 
+--------------------------------------------------+---------------------------+ 
| Christopher Howard/Christopher Wren              |                           | 
+--------------------------------------------------+---------------------------+ 
 
 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 BOAMGGZRZGGGLZZ 
 

Cobra Bio-manufacturing (LSE:CBF)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Cobra Bio-manufacturing (LSE:CBF)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024